This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
Dickinson PJ, Bannasch M, Thomasy SM et al. (2020) Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis. Journal of Veterinary Internal Medicine34, 1587–1593
Pedersen NC, Perron M, Bannasch M et al. (2019) Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. Journal of Feline Medicine and Surgery21, 271–281
Tasker S, Addie D, Hartmann K et al. (2024) Feline infectious peritonitis. ABCD Guidelines. Available from: www.abcdcatsvets.org
Taylor S and Barker E (2021) FIP: Hope on the horizon for cats with FIP. Vet Times31 Aug 2021
Taylor SS, Coggins S, Barker EN et al. (2023) Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020-2022). Journal of Feline Medicine and Surgery 25, 1098612X231194460
Zuzzi-Krebitz A-M, Buchta K, Bergmann M et al. (2024) Short treatment of 42 days with oral GS-441524 results in equal efficacy as the recommended 84-day treatment in cats suffering from feline infectious peritonitis with effusion - a prospective randomized controlled study. Viruses16, 1144
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
